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Abstract.  Whereas it has been demonstrated that 
muscle and nonmuscle isoactins are segregated into 
distinct cytoplasmic domains, the mechanism regulat- 
ing subcellular sorting is unknown (Herman,  1993a). 
To reveal whether isoform-specific actin-binding pro- 
teins function to coordinate these events, cell extracts 
derived from motile (Era) versus stationary (Es) 
cytoplasm were selectively and sequentially fraction- 
ated over filamentous isoactin affinity columns prior to 
elution with a KC1 step gradient.  A polypeptide of in- 
terest,  which binds specifically to/3-actin filament 
columns, but not to muscle actin columns has been 
conclusively identified as the ERM family member, 
ezrin.  We studied ezrin-/3 interactions in vitro by 
passing extracts (Era) over isoactin affinity matrices in 
the presence of Ca2+-containing  versus Ca2+-free 
buffers, with or without cytochalasin D.  Ezrin binds 
and can be released from/3-actin Sepharose-4B in the 
presence of Mg2+/EGTA  and  100 mM NaC1 (at 4°C 
and room temperature),  but not when affinity fraction- 
ation of Em is carried out in the presence of 0.2 mM 
CaC12 or 2/~M cytochalasin D. N-acetyl-(leucyl)2- 
norleucinal  and E64, two specific inhibitors of the 
calcium-activated protease, calpain I, protect ezrin 
binding to B actin in the presence of calcium. 
Moreover, biochemical analysis of endothelial lysates 
reveals that a calpain I cleavage product of ezrin 
emerges when cell locomotion is stimulated in re- 
sponse to monolayer injury. Immunofluorescence anal- 
ysis of leading lamellae reveals that anti-ezrin  and 
anti-~-actin  IgGs can be simultaneously co-localized, 
extending the results of isoactin affinity fractionation 
of Em-derived  extracts and suggesting that ezrin and 
B-actin interact in vivo. To test the hypothesis that ez- 
rin binds directly to B-actin,  we performed three sets 
of studies under a  wide range of physiological condi- 
tions (pH 7.0-8.5) using purified pericyte ezrin and ei- 
ther o~- or B-actin.  These included co-sedimentation, 
isoactin affinity fractionation,  and co-immunoprecipi- 
tation.  Results of these experiments reveal that purified 
ezrin does not directly bind to ~-actin filaments, either 
in solution or while isoactins are covalently cross- 
linked to Sepharose-4B. This is in contrast to our 
finding  that ezrin and ~-actin could be co-immunopre- 
cipitated or co-sedimented from E,~-derived  cell ly- 
sates.  To explore whether calcium transients  occur in 
cellular domains enriched in ezrin and ~-actin,  we 
mapped cellular free calcium in endothelial mono- 
layers crawling in response to injury.  Confocal imag- 
ing of fluo-3 fluorescence followed by simultaneous 
double antibody staining  reveals a transient rise of 
free calcium within ezrin-/3-actin-enriched  domains in 
the majority of motile cells bordering the wound edge. 
These results support the notion that calcium and cal- 
pain I modulate ezrin and B-actin interactions during 
forward protrusion formation. 
ECE~qT studies indicate that the contractile  protein iso- 
forms play distinct roles in facilitating  cell function. 
For the isoactins,  there is an emerging  literature  to 
indicate  that  this  is,  indeed,  the case (Rubenstein,  1990; 
Herman,  1993a).  Three lines  of evidence currently exist. 
First, localization  studies using isoform-specific  antibodies 
reveal  that  in cells simultaneously expressing  muscle and 
nonmuscle isoactins  (e.g., myocytes,  smooth muscle cells, 
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and pericytes), c~-(muscle) isoactins are largely restricted to 
sarcomeres and  stress  fibers  (Lubit and  Schwartz,  1980; 
Herman,  1993b; Herman and Dgtmore,  1985; DeNofrio et 
al., 1989; Otey et al., 1988). In contrast,/3-  (nonmuscle) ac- 
tin is positioned in cytoplasm that is actively being remod- 
eled, such as the membrane ruffles and forward protrusions 
(Hoock et al., 1991; Herman, 1993a; Hill et al., 1994). Sec- 
ond, over-expression  of/3- versus 3'-nonmuscle isoactins  in 
C2 myoblasts  results  in differential  effects on cell surface 
area and morphology,  respectively (Schevzov et al.,  1992). 
And lastly, cultured cell lines expressing variants of/3-actin 
display such phenotypes as cytochalasin  resistance,  altered 
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Leavitt et al., 1987; Leavitt and Bushar, 1982). These obser- 
vations point to functionally diverse roles for the conven- 
tional actin isoforms and raise questions about the manner 
in which their subcellular segregation is achieved. 
Does mRNA targeting explain the non-random distribu- 
tions of isoactins observed in living cells? Pioneering studies 
demonstrated an association of mRNA with the cytoskele- 
ton, since treatment of ceils with cytochalasin B or RNAase 
A disrupted polysome distribution (Lenk et al., 1977). More 
recently it has been shown that actin mRNA localization can 
be randomized when the cellular actin network is disrupted 
(Sundell and Singer,  1991). mRNA anchoring is not, how- 
ever, disrupted by puromycin or cycloheximide, suggesting 
that nascent polypeptides do not participate in mRNA local- 
ization (Sundell and Singer,  1990, 1991). Insights into isoac- 
tin mRNA targeting have also recently emerged from in situ 
hybridization studies on transfected cells harboring plasmids 
containing reporter genes, which were linked upstream of 
the ~-actin 3' UTR. These results reveal that a ~-actin mRNA 
targeting  "address" exists  in  this  non-coding  region  and 
directs message localization (Kislauskis et al., 1993, 1994; 
Hill and Gunning, 1993). These results could help to explain 
the  selective placement of ~-actin mRNA within leading 
lameUae,  when  locomotion  is  initiated  following  injury 
(Hoock et al.,  1991; Herman,  1993c).  Yet, in spite of this 
documented ~-actin mRNA targeting, evidence is lacking to 
suggest that a cortical, functionally intact translational ma- 
chinery either contributes to the/3-actin found in these distal 
cytoplasmic domains or is sufficient to sequester it within the 
cytoskeletal-plasma membrane interface once nascent poly- 
peptides are produced. 
Mechanisms mediating/3-actin dynamics in non-erythroid 
cells may mirror actin organization in erythrocytes, where 
~-actin is the lone isoform that is expressed (Pinder and 
Gratzer,  1983).  In erythrocytes, ~actin is found as short 
oligomers bound by spectrin tetramers near its filament ends 
(reviewed by Bennett, 1985).  Protein 4.1 and ankyrin foster 
the formation of this two-dimensional spectrin/actin lattice 
and join it to the plasma membrane via their association with 
integral membrane proteins.  In  a  similar fashion, homo- 
logues of protein 4.1  may act to sequester/3-actin in non- 
erythroid cells.  Could ezrin,  radixin,  moesin, merlin, or 
talin, all of which are protein 4.1 homologues of the ERM 
family of putative tumor suppressor proteins (Tsukita et al., 
1993)  help to regulate isoactin dynamics in non-erythroid 
cells? Clearly, ezrin has been localized within membrane 
ruffles and cellular projections (Bretscher, 1983, 1989; Birg- 
bauer et al.,  1989),  domains that we have previously re- 
ported to be enriched in ~-actin (Hoock et al.,  1991; Her- 
man, 1993c).  And domain mapping studies predict that the 
COOH-terminal portion of ezrin may associate with the ac- 
tin cytoskeleton (Algrain et al., 1993; Turenen et al., 1994). 
However, in spite of the "historical" co-localization of these 
two proteins, ezrin's role as a bona fide actin-binding protein 
remains controversial since the full length molecule fails to 
bind c~-actin in vitro (Bretscher,  1983, 1991). 
In light of what is known about the biochemical properties 
and localization of/3-actin and ezrin in non-erythroid cells, 
we asked whether ERM family members function to spa- 
tially restrict or sequester/~-actin within cortical cytoplasm. 
To these ends, we used isoactin affinity fractionation to iden- 
tify candidate polypeptides that preferentially or exclusively 
bind to/3- versus c~-actin filaments. Application of cytoplas- 
mic extracts derived from motile cytoplasm (Era: membrane 
ruffles,  pseudopods,  and  leading  lamallae)  onto  isoactin 
affinity columns reveals a population of four to six polypep- 
tides that preferentially associate with/3-, but not c~-actin illa- 
ments.  Western  blotting  of the  /3-actin  column  elutions 
reveals that one of the polypeptides is ezrin. In vitro asso- 
ciation of ezrin and fl-actin occurs in the presence of physio- 
logic salts (KC1, MgCI2) and EGTA, but not in the presence 
of micromolar levels of free calcium or cytochalasin D. The 
calcium-dependent  inhibition  of  ezrin  association  with 
/3-actin can be reversed with specific inhibitors of the cal- 
cium-activated protease, calpain I, or cytochalasin D. While 
an in vitro association of ezrin and #-actin can be demon- 
strated by co-precipitation of ezrin from Em, ezrin does not 
directly bind  to  ~-actin  since  it  can  neither be  co-sedi- 
mented, co-precipitated, nor retained on/3-actin affinity ma- 
trices when the purified molecules are mixed together. Using 
confocal microscopy and the calcium-sensitive fluorescent 
dye, fluo-3,  we document transient elevations  in cytosolic- 
free  calcium occurring  in  moving  regions  of cytoplasm 
where/3-actin and ezrin are positioned, and where calpain 
I-mediated ezrin proteolysis can be demonstrated. The com- 
bined results of these biochemical experiments and localiza- 
tion studies suggest that calcium-activated cleavage of ezrin 
from ~-actin could facilitate isoactin dynamics during for- 
ward protrusion formation as advancing cytoplasm is  re- 
modelled during cell motility. 
Materials and Methods 
Vascular Cell Culture 
Bovine vascular cell cultures were established as previously published (Her- 
mana and Dg,  more, 1985).  Bovine retinal endothelial cell (EC) I and peri- 
cyte cultures were grown in DME supplemented with 5 % calf serum, L-glu- 
tamine,  and  antibiotics;  pericytes  were  cultured  through  their  second 
passage in DME containing 10% calf serum, L-glutamine, and antibiotics. 
Antibodies 
Isoform-specific polyclonal  antibodies  were  raised  against  ~  vascular 
smooth muscle and nonmuscle (fl) actin and affinity selected as previously 
described (Herman and  D~more,  1985;  Herman,  1988;  Hoock et al., 
1991).  Mouse monoclonal anti-ezrin IgG was purchased from ICN Bio- 
medicals (Costa Mesa, CA). Anti-ezrin IgG was a gift from Dr. Anthony 
Bretscher (Cornell University, Ithaca, NY; Bretscher, 1983).  One series of 
localization  studies  was  also  performed  using  monoclonal  anti-ezrin 
(13H9),  provided by Dr. Frank Solomon (MIT, Boston, MA). 
Purification of  Actin lsoforms 
Muscle Actin.  Acetone powder from chicken skeletal and bovine aortic 
smooth muscle was prepared according to previously published procedures 
(Spudich and Watt,  1971; Herman and Pollard, 1979).  Actin was extracted 
from an acetone powder in G buffer (2 mM Tris-HC1,  0.2 mM CaCI2, 0.2 
mM DTT, 0.2 mM ATE 0.02% NAN3) and cycled through one round ofpo- 
lymerization-depolymerization  prior to gel permeation chromatography on 
Sephadex G-150. 
Erythrocyte Actin.  Erythrocyte acetone powder was prepared as previ- 
ously described (Puszkin et al., 1978), with several modifications. Acetone 
powder was extracted twice using 15 ml G buffer/gram powder for 2 h at 
4°C. After clarification at 27,000 g for 1 h at 4"C, the extract was fraction- 
ated over DEAE cellulose (DE-52;  Sigma Chem.  Co., St.  Louis, MO) 
1. Abbreviations used in this paper: CNBr, cyanogen bromide; DSP, dithio- 
bis(succinimidylpropionate); EC, endothelial cells; LB, lysis buffer. 
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NaCI.  Actin eluted from the column between 0.15-0.25  M  NaCI.  These 
fractions were pooled, concentrated to 4-6 ml, and applied to a 3 cmx 
48 cm Sephadex G-150 column equilibrated with G buffer. Peak actin frac- 
tions were then pooled, and filaments were assembled at room temperature 
in 2  mM MgCI2  and  100 mM KCI.  After centrifugation at  100,000  g, 
F-actin was disassembled in  G  buffer,  sterile-filtered, and  reehromato- 
graphed on G-150 Sephadex prior to storage on ice. SDS-gel electrophore- 
sis as well as isoelectric focusing of purified actins demonstrate that each 
isoactin pool is greater than 98% pure, both at the level of isoactins and 
with respect to other contaminating proteins. 
Preparatin of  F-actin Affinity Matrices 
Isoactins were covalently cross-linked to Sepharose-4B by cyanogen bro- 
mide (CNBr) activation as described (Herman and Pollard, 1979).  Briefly, 
20 ml Sepharose-4B was washed three times with deionized water at 40C 
by pelleting/resnspension. Washed Sepharose-4B was resnspended in an 
equal volume of dH20 and allowed to warm to 15°C prior to activation 
with CNBr (0.25  g/ml beads). The pH was held between 10.5-11.0 using 
6 N NaOH for 15 rain, prior to washing (2 liters, 0.1 M Sodium borate, 
pH 8.8).  Following dialysis in borate buffer, equal volumes of phalloidin- 
stabilized actin (0.5 mg/ml, 11.6 t~M; 1:4 too|at ratio; phalloidin/actin) and 
washed CNBr-activnted Sepharose-4B were mixed overnight at 40C.  Un- 
bound actin was removed by pelleting and resuspension in excess berate 
buffer prior to quenching with 100 mM glycine, 20 mM Tris-HCl, 0.2 mM 
CaC12, pH 7.8, overnight at 4°C. The concentration of bound actin ranged 
from between 4.1  and  5.0  ~M  (0.17-0.22)  mg/ml.  Phalloidin-stabilized 
F-actin bound to Sepharose-4B was either used immediately or stored on 
ice in 20 mM Tris-HCl, pH 7.8, 70 mM KCI, 0.2 mM DTT, 0.2 mM ATE 
0.1 mM CaCl2, 0.02% NAN3. 
Extraction of  Retinal Pericytes  for 
Affinity Fractionation 
Subconfluent pericyte cultures were washed three times with PBS at room 
temperature prior to extraction for 10 rain at room temperature in lysis 
buffer (LB) (3 ml/106 cells). LB contains either 0.1% Triton X-100 or 34 
mM octyl-glucoside, 40 mM Hepes, pH 7.15, 50 mM Pipes, pH 6.9, 75 mM 
NaCI,  1 mM MgC12, 0.5 mM EGTA,  1 mM PMSF, 0.1 mg/ml pepstatin, 
0.1 mg/ml SBTI, 0.1 mM TLCK, 0.1 mM TPCK,  1 mM TAME, and 2.5 
mM sodium orthovanadate. Alternatively, cells were lysed in LB that con- 
tained either 0.2 mM CaCi2 or 0.2 mM CaCI2 with 0.1 mg/ml calpain in- 
hibitor I (N-acetyl-[leucyl]2-norleucinal; Boehringer-Mannheim Biochem- 
icals,  Indianapolis,  IN)  (Tsujinaka  et al.,  1988).  In other experiments, 
5 tzM E,64 (L-trans-epoxysuceinyl-leueylamido  [4-guanidino]butane)  (Sigma 
Chem. Co.), another inhibitor of calpain I, was used (Barrett et al., 1982). 
After removal of the Triton-soluble fraction, the Triton-insoluble fraction 
was dissolved using LB containing 0.1% SDS. Fractions were clarified at 
20,000 g, and then dialyzed against three changes of G buffer containing 
either 0.2 mM CaCI2,  0.2 mM MgC12/0.5 mM EGTA,  100 mM NaCI at 
either 0°C or room temperature. Protein content was determined colori- 
metrically (Bio-Rad-Laboratories, Richmond, CA). 
lsoactin Affinity Fractionation 
Lysates (Triton-soluble, 1-2  x  106 cells) that were dialyzed as described 
above were mixed for 4-20 h with muscle-actin Sepharose-4B, either at 4"C 
or room temperature. Unbound protein was collected, split into two equal 
fractions and re-applied to both or- and/~-actin Sepharose-4B. Following ex- 
haustive washing, bound proteins were eluted using a 0.1, 0.5,  and 1.0 M 
KCI  step gradient. Fractions were collected into chilled tubes, dialyzed 
(versus G buffer), and then lyophilized prior to boiling in SDS-PAGE sam- 
ple buffer containing 10% 2-mercaptoethanol and electrophoresis on 10% 
SDS-PAGE mini gels. Fractions were either directly visualized by silver 
staining or transferred to nitrocellulose for Western blotting with anti-ezrin 
or -actin antibodies using previously described procedures (Herman, 1988; 
DeNofrio et al.  1989). 
Co-immunoprecipitation of  Ezrin and Actin from 
Lamellar Extracts 
Retinal  pericytes were  labelled  for  10  h  with  85  t~Ci/ml  [3SS]methio- 
nine/[35S]cysteine  (Translabel; ICN Biomedical), in methionine- and cys- 
teine-deficient DME supplemented with 10%  calf serum, glutamine, and 
antibiotics. Media was briefly exchanged with three washes of PBS.  To 
stabilize any low-affinity, protein-protein interactions against the detergents 
present in the lysis and immunoprecipitation  buffers, cells were treated with 
the thiol-reducible, cross-linking agent dithiobis(suecimmidylpropionate) 
(DSP) (Pierce Chem. Co., Rockford, IL) (0.25  raM) in PBS containing 
0.002 % Digitonin for 10 rain at room temperature. Cells ware washed three 
times with 10 mM Tris-HC1,  150 mM NaCI, pH 7.4,  to quench residual 
DSP,  prior  to  lysis  in  0.5  ml  0.5%  Triton  X-100,  40  mM  sodium 
pyrophosphate, pH 7.5, 150 mM NaCI, 1 mM EGTA, 1 mld EDTA, 2 mM 
DTT, 5 mM ATP, 5 mM iodoacetamide, supplemented with 0.1 mM PMSF, 
0.1 mg/ml soybean trypsin inhibitor, 0.1 mg/ml pepstatin, 2.5 mM sodium 
orthovanadnte, 0.1 mM TLCK, 0.1 mM TPCK, and  1 m.M TAME (LBi) 
for 10 rain at room temperature. Immunoprecipitation was performed as 
previously described (Yost and Herman, 1990).  To ensure loading of sam- 
ples, TCA precipitation was performed on duplicate samples to determine 
incorporation of [~SS]methionine/cysteine  into total cell protein, and equal 
counts were loaded. Samples were resolved on 7.5%  SDS-PAGE and then 
processed for fluorography (Laskey and Mills, 1975). 
Quantification of  Ezrin in Cell Lysates 
To quantify the amount of ezrin present in vascular cell lysates, immunopre- 
cipitation was performed from pericyte Em as described above (Yost and 
Herman, 1990). Immunoprecipitated ezrin was resolved by SDS-PAGE and 
transferred to  Immobilon PDVF membrane (Millipore Corp.,  Milford, 
MA).  After staining  with  0.1% Coomassie R-250,  the  ezrin  band  (as 
identified by parallel Western blotting) was excised and treated with 6 N 
HCI for 24 h  at  ll0°C.  Amino acid analysis was then performed using 
PICO.TAG amino acid analysis sytem (Waters,  Milford, MA) in the protein 
analysis facility (Department of Physiology, Tufts University, Boston, MA) 
(Cohen et ai., 1984). The identity of the excised band was confirmed as ez- 
tin by comparing the mole fraction of amino acids present to those predicted 
(Gould et al., 1989). The concentration of  ezrin in pericytes was determined 
to be 7.7 pmol/106 ceils. 
Purification of  Pericyte Ezrin 
Native, intact ezrin was purified from cultured bovine retinal pericytes es- 
sentially as described (Bretscher, 1983, 1986) with the following modifica- 
tions. 2.5  ×  107 cells were lysed in 4 ml LB per 150 mm dish as described 
for isoactin affinity fractionation (see above). Following clarification of the 
ezrin-containing  lysate at 27,000 g for 15 rain at 4°C, it was dialyzed against 
three changes of 10 mM imidazole, pH 6.7, 20 mM NaCI,  1 mM DTT, 
and 0.1  mM PMSF at 0°C.  The lysate was clarified by centrifugation at 
100,000  g for 30 rain, 4°C prior to application onto a 1.0 × 4.0 cm hydrox- 
ylapatite column pre-equilibrated with 100 mM KH2PO4,  pH 7.0. Ezrin- 
containing fractions were eluted with a 40 ml linear gradient of KH2PO4 
(0.1-0.8 M) containing 5/~M E64 to inhibit proteolysis, l-nil fractions were 
collected and  analyzed by  10%  SDS-PAGE.  Ezrin-containing fractions 
were identified by ELISA and subsequently pooled prior to dialysis against 
10 mM Tris-C1, pH 7.5,  1 mM DTT, 0.5 mM EGTA. The pooled fraction 
was re-clarified prior to loading onto a 0.5  x  1.0 cm column of DEAE cellu- 
lose (DE-52; Sigma Chem. Co.) equilibrated in 10 mM Tris. pH 7.5, 1 mM 
DTT,  0.5 mM EGTA. Fractions were ehited with a linear NaC1 gradient 
(0-0.2 M). Ezrin elutes in the middle of the gradient (0.1 M NaCI). Ezrin 
purity was assessed by SDS-PAGE, and judged to be >92% pure by den- 
sitometry. Its identity was also confirmed by Western blotting (see above). 
Purification of ezrin by this affinity isolation procedure yielded a 1,000-fold 
enrichment where 15-20 t~g of ezrin could be purified from 15 nag of start- 
ing material. Ezrin was stored in 10 mM Tris-C1 pH 7.5,  1 mM DTT,  20 
mM NaC1, 0.5 mM EGTA~ 0.02%  NaN3 on ice. 
Interaction of Pericyte Ezrin with Gel-filtered  lsoactins 
Co-sedimentation Analysis.  Gel-filtered (0.5 #M) skeletal muscle (or) and 
erythrocyte (B) actin were assembled separately into filaments following a 
second round of polymerization. Actin assembly proceeded in the barrel of 
a 1-cc syringe at 37"C for 30 min prior to shearing through a 25-gauge nee- 
dle. This yielded many foreshortened filaments, maximizing the number of 
filament ends. Filament lengths prior to shearing were 3.7 +  0.65/~m, and 
following shearing were 0.75 +  0.2/~m as measured by negative stain trans- 
mission electron microscopy. 290 t~l of sheared filaments were added to 
prewarmed microfuge tubes containing 10 td of either F-actin buffer or 40 
~g/ml ezrin. Either ezrin-containing lamellar lysates or purified ezrin was 
mixed with isoactin filaments by rotation for an additional 30 rain at either 
Shuster and Herman Ezrin-~t-Actin Interactions  839 room temperature or 37°C. The mixtures were then pelleted by centrifuga- 
tion at 110,000 g in a Beckman  TLA 100.2 rotor (Beckman Instruments, 
Palo Alto, CA) for 35 min at 15°C. The supernatants were removed,  and 
the proteins present in the supernatant and pellet fractions quantitatively 
precipitated using 3 vol of ice cold ethanol (100%).  Protein pellets  were 
dried in a Speedvac (Savant, Farmingdale,  NY), and re-solubilized  in boil- 
ing SDS-PAGE sample buffer. Supernatant and pellet fractions were ana- 
lyzed by 10% SDS-PAGE and Western blotting (DeNofrio  et al.,  1989). 
lmmunoprecipitation of Ezrin-Actin  Complexes. Twice-polymerized 
isoactin filaments  were incubated with pericyte ezrin as described above. 
Anti-a~tin IgG-coated Atflgel  beads (Bio-Rad  Laboratories, Richmond, 
CA) were prepared exactly  as described (Yost and Herman,  1990).  Ez- 
rin-actin (1:300  molar ratio; ezrin/actin) mixtures were incubated with 
anti-actin IgG-coated  affigel beads at a 4 molar excess of IgG to actin for 
3 h at room temperature.  Immunoprecipitates were washed three times by 
pelleting,  and resuspension in F-actin buffer prior to boiling in SDS-PAGE 
sample  buffer  and Western blotting for ezrin using mouse monoclonal 
anti-ezrin IgG (ICN  Biomedicals)  and alkaline phosphatase-conjugated 
goat anti-mouse IgG (Bio-Rad  Laboratories). 
lsoactin A~inity  Fractionation of Purifwd Ezrin. To further assess 
whether purified pericyte ezrin could bind directly to the isoactin affinity 
columns,  0.5  ~g ('~106 cell equivalents)  ezrin in G buffer (with 0.2 mM 
MgClz, 0.5 mM EGTA,  5:100 mM NaC1) was mixed with 0.5 ml of 5 #M 
(c~ or #) actin Sepharose-4B  in a fashion identical  to that described for 
affinity fractionation of Era. Isoactin Sepharose-4B-ezrin mixtures were in- 
cubated for 3 h at room temperature, and the unbound fractions were col- 
lected.  Columns were washed,  and bound protein eluted with 1 M NaC1. 
Protein present in the unbound fractions and 1.0 M  NaCI elutions were 
quantitively precipitated (with ethanol), and probed for the ezrin by Western 
blotting. 
Simultaneous Localization of  Ezrin and B-Actin by 
Double Antibody Staining 
Bovine  endothelial cells were plated at confluence,  injured with a  fire- 
polished pasteur pipet and allowed to recover for 60 rain at 37°C, and then 
were fixed and processed for indirect immunofluoreseence  according to pre- 
viously published procedures (Hoock et al.,  1991). For ezrin localization, 
2 #g/ml affinity-purified, rabbit anti-ezrin IgG (Bretscher,  1983) or 5 #g/ml 
monoclonal anti-ezrin IgG (ICN Biomedicals)  were used. For anti-/~-actin 
IgG localization,  5-50 ~g/ml affinity-selected antibodies were used (Hoock 
et al.,  1991). Cells processed for co-localization  were viewed using either 
an Odyssey laser scanning confocal microscope  (Krypton-argon laser; No- 
ran Instruments, Middleton, WI) or a Zeiss IM 35 inverted fluorescent mi- 
croscope equipped  with a 50 W Hg lamp and a Zeiss planapochromat oil 
immersion objective lens (NA 1.4). Confocal  images  were stored in TIF 
files (Metamorph; Universal Imaging, West Chester, PA), and fluorescence 
micrographs were recorded with Tri-X film (Herman and D'Amore,  1985). 
Localization of  Free Calcium in Motile 
Endothelial Cells 
To  examine  calcium  transients  in  migrating  cells,  resting  endothelial 
monolayers were injured in the presence of 5 #M Fluo-3 as described above 
(Molecular Probes, Eugene, OR). Coverslips with cells attached were then 
mounted on a warmed chamber slide and allowed to recover 30-120 rain 
at 370C on the confocal microscope stage.  Image capture,  processing and 
quantification  was  accomplished  using Metamorph (Universal Imaging, 
West Chester,  PA). Coverslips with cells attached were then processed for 
simultaneous anti-ezrin and anti-~-actin indirect immunofluorescence.  Ez- 
rin and/3-actin images were paired and scaled using Optimas  (Bioscan In- 
corperated, Edmonds,  WA) and Adobe Photoshop (Adobe Systems Incor- 
porated, Mountain View, CA). To record the frequency of Ca  2+ transients 
in the leading lamellae of motile cells, random fields of cells bordering the 
v~und edge  were  selected  by transmitted light microscopy,  and the inci- 
dence of Fluo-3  fluorescence  was recorded  for  100 cells per experiment 
(n =  3). 
Results 
lsoactin Affinity Fractionation: Identification of 
{3-Actin-binding Proteins 
Our  earlier  work  revealed  a  selective,  non-random distri- 
bution of ~-actin  and  its  encoding  mRNA  within  the  for- 
ward protrusions of locomoting endothelial cells and fibro- 
blasts  recovering  from  monolayer  injury  (Hoock  et  al., 
1991).  Since then,  we have tested  whether retention of lo- 
cally  translated  or  recently  transported  B-actin  (to  the 
membrane-associated,  cortical  cytoskeleton)  is  dependent 
upon/~-actin-specific  binding  protein(s).  To this  end,  we 
prepared  Sepharose-4B  columns  containing  homogeneous 
pol:ulations of phalloidin-stabilized  actin filaments purified 
from either skeletal  muscle (o~; chicken),  vascular smooth 
muscle  (or; bovine) or erythrocytes  (8;  bovine or human). 
Sequential fractionation of extracts derived from spreading 
cytoplasm  (Era) over  these  isoactin  affinity  matrices  af- 
forded an opportunity to identify putative or- and/or/3-actin- 
specific  binding proteins  (bABPs). 
Based on the solubility properties of the isoactin network 
present in mobile projections (DeNofrio et al., 1989; Ruben- 
stein,  1981), we presumed that bABPs would also be present 
in  F_~, associated  with  their  respective  isoactins  using  ei- 
ther  34  mM  octyl-glucoside  or 0.1% Triton  X-100.  When 
Em (250  #g/ml)  (Fig.  1,  lane  1 )  is  percolated  over  5  /xM 
a- (skeletal or smooth muscle) actin columns, 4 % of the pro- 
tein pool (10 izg bound/ml o~-actin Sepharose-4B) is retained. 
Figure  I.  Affinity  selection  of fl-actin-binding proteins.  Retinal 
pericytes were lysed in a buffer containing 0.1%  Triton X-100 (as 
described in Materials and Methods). Following dialysis to remove 
detergent, lysate (lane 1 )  was applied to skeletal muscle-Sepha- 
rose-4B (o~-actin). Bound proteins were eluted using 1 M KC1 (lane 
2).  The flow-through (lane 3)  was  re-applied to erythrocyte ac- 
tin-Sepharose-4B (/3-actin) (in the presence of 0.2 mM MgCI2/0.5 
mM EGTA  [lane 4] or 0.2 mM CaCI2  [lane 5]),  and bound pro- 
teins eluted with 1.0 M  KCI (lanes 4 and 5).  The eluted fractions 
were  resolved  on  10%  SDS-PAGE gels  and visualized by  silver 
staining. 
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with 1.0 M KCI (Fig.  1, lane 2). Inclusion of 100 mM NaCI 
in the dialysis and affinity fractionation buffers does not alter 
the constellation of polypeptides eluted (data not shown). 
SDS-gel electrophoresis and silver staining reveals between 
20-22  polypeptides  present  in  fractions  released  from 
ot-actin-Sepharose-4B. These include several in the lower 
(34, 37/38, 40/43, 51,  53 kD), middle (69/73,  78, 98,  100, 
105/107,  118 kD), and high molecular weight ranges (200, 
250 kD) (Fig.  1, lane 2). Western blotting of these polypep- 
tides electrophoresed and transferred to nitrocellulose indi- 
cate that myosin II, fodrin (a chain), and caldesmon (low and 
high  molecular  weight  isoforms)  are  amongst  the  actin- 
binding proteins that can be released from o~ skeletal and 
~-smooth  muscle  actin  Sepharose-4B.  While these  actin- 
binding proteins share identical elution profiles from c~- and 
/3-actin affinity columns, dot blot overlay analysis reveals that 
one  polypeptide,  p34  calponin,  preferentially binds  illa- 
ments of smooth muscle actin (Shuster, C. B., I. M. Herman, 
manuscript in preparation). 
When the flow-through fraction (Fig.  1, lane 3), which is 
not retained on c~-actin-Sepharose-4B, is reapplied to 5 #M 
~-actin-Sepharose-4B, only 1.5-3 % of the total Em protein 
pool (4-7.5 t~g bound/ml ~-actin-Sepharose) is retained (Fig. 
1, lane 4). Silver staining of this fraction reveals 11 polypep- 
tides, 5 of which were present in the a-actin-binding frac- 
tions (Fig. 1, lane 2). The remaining six polypeptides prefer- 
entially bind and can be released from fl-actin Sepharose-4B 
(Fig.  1, lane 4). These include polypeptides of 35,  65,  and 
doublets  of 70-73  and  80/83  kD.  These  bABPs  can  be 
released from the fl-actin affinity columns using 1.0 M KC1 
(Fig. 1, lane 4). While inclusion of 100 mM NaC1 in affinity 
fractionation buffers does  not affect the  binding  of these 
bABPs,  inclusion of 0.2 mM CaCI2 reduces or obliterates 
the association of  two polypeptides, most notably those poly- 
peptides at 65 and 80/83 kD (Fig.  1, lane 5). 
Ezrin Present within Lamellar Extracts Specifically 
Associates with ~, but Not ~-Actin Filaments: Calcium 
Sensitivity and Calpain Activation 
Ezrin,  along with other ERM  family members,  has  been 
localized within the cortical cytoskeleton; but intact, native 
ezrin does not bind muscle actin in vitro (Bretscher,  1983, 
1989; Birgbauer and Solomon, 1989). Therefore, we wished 
to explore whether ezrin was  one of the ~-actin-specific 
binding proteins present in the 65-85 kD elutions isolated 
from/3-actin Sepharose-4B. After probing this Era-derived 
fraction with monoclonal or polyclonal anti-ezrin IgGs, we 
see that ezrin does not bind parallel ot-actin columns. How- 
ever, ezrin present in the a-actin Sepharose-4B flow-through 
specifically binds and can be released from fl-actin columns. 
With a KC1 step gradient, 20 % of the bound ezrin is released 
with 0.1 M KCI, 78% with 0.5 M, and 2% with 1.(3 M KC1. 
Since >198% of the bound ezrin can be released with 0.5 M 
KC1, 1.0 M KC1 was used for all further experiments to strip 
fl-actin columns of associated ezrin (Fig.  2). 
When Em lysates are fractionated in the presence 0.2 mM 
CaC12, the immunoreactive ezrin species is barely detect- 
able, even in the 1.0 M  KC1 releasates derived from either 
or- or fl-actin affinity columns at 4°C or room temperature 
(Fig. 2, lanes 4 and 5; respectively; Table I). Based on den- 
sitometric analyses, there is roughly a 20-fold difference in 
Figure 2. Calcium-calpain  I regulates fl-actin-ezrin interactions. 
Lamellar lysates were absorbed over cf-actin  Sepharose-4B, and the 
flow-through was  re-applied  to parallel  ct- and  /~-actin affinity 
columns. To test the effects of divalent cations on the association 
of  ezrin and fl-actin, extracts were prepared, and subsequent isoac- 
tin affinity fractionation was performed in the presence of 0.2 mM 
CaCI2 (lanes 4 and 5), 0.2 mM MgCI2/0.5 mM EGTA (lanes 8 
and 9), or Mg2÷/EGTA with  100 mM NaCI (lanes 10 and 11). 
Further, to examine whether the interaction of ezrin and I$-actin 
was regulated by calpain I, lysates were derived and isoactin affinity 
fractionation  performed  in  buffers  containing  0.2  mM  CaCI2, 
which also included 5 #M E64, a specific inhibitor of calpain I 
(lanes 6 and 7). Finally, to assess whether ezrin-binding to/3-actin 
occurred via the ends of  the isoactin filament or along their lengths, 
phalloidin-stabilized  isoactin  filaments covalently attached  to 
Sepharose 4B were treated with 2 #M cytochalasin D prior to per- 
colatin of  lamellar extracts over  isoactin columns (lanes 12 and 13). 
Proteins bound  and eluted  from isoactin affinity columns were 
resolved on 10% PAGE  gels, transferred to nitrocellulose, probed 
with  1 #g/ml  anti-ezrin  IgG, and visualo_r..xl with  1 #g/ml  goat 
anti-rabbit IgG-horseradish peroxidase. (Lane 1 ) Lysate prepared 
in the presence of 0.2 mM CaCI2. (Lane 2) Lysate prepared in the 
presence of 0.2 mM MgCI2/0.5 mM EGTA. (Lane 3) Lysate pre- 
pared in the presence of 0.2 mMCaCI2 with 5 I~M E64.  (Lane 4) 
a-actin-Sepharose  eluted with 1 M KCI. (Lane 5) fl-actin-Sepha- 
rose eluted with 1 M KCI. (Lane 6) a-actin-Sepharose  eluted with 
1 M KCI. (Lane 7)/3-actin-Sepharose eluted with 1 M KCI. (Lane 
8) tx-actin-Sepharose eluted with 1 M KC1. (Lane 9) #-actin-Seph- 
arose eluted with 1 M KCI. (Lane 10) t~-actin-Sepharose eluted 
with 1 M KCI. (Lane 11 ) ~-actin-Sepharose elnted with 1 M KCI. 
(Lane 12) fl-actin-Sepharose eluted with 0.5 M KC1. (Lane 13) Cy- 
tochalasin D-pretreated/3-actin-Sepharose eluted with 0.5 M KC1. 
ezrin released (from f3-actin columns) when affinity fraction- 
ation is performed in the presence of EGTA (n =  7) versus 
Ca  2+ (n  =  7) (Fig. 2, lane 9; Table I). Ezrin-/3-actin inter- 
actions are maintained when calcium is chelated, and under 
low (G buffer) or near physiologic (100 mM NaCI) salt con- 
centrations (Fig. 2, lane 11 ). Under all of  these experimental 
conditions, ezrin binding to parallel skeletal or smooth mus- 
cle actin columns is not measurable (n =  14) (Fig. 2, lanes 
4,  6, 8, and 10). 
To learn whether the effect of calcium on the association 
of ezrin with B-actin is via calcium-activated proteases, Em 
lysates were derived and fractionated in the presence of 0.2 
mM CaClz with or without peptide inhibitors of the neutral 
cysteine proteases, calpain I, and calpain II. A report in the 
literature has indicated that calpain I catalyzes a limited pro- 
teolysis of ezrin, yielding a major species of 55 kD (Yao et 
al.,  1993). Indeed, western blotting reveals a 55-kD break- 
down  product  (ezrin  p55)  present  in  E~, prepared  in  the 
presence  of 0.2  mM  CaCI2  (Fig.  2,  lane  I),  which  in- 
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20oc  4°C 
Percent control*  Molar ratio:~  Percent  control  Molar  ratio  Percent  control  Molar  ratio  Percent  control  Molar  ratio 
Ca  2+  5.6  0.24  5.8  0.23  3.4  0.13  ND§  ND 
Ca2÷/E64  61  2.40  ND  ND  57  2.24  ND  ND 
EGTA  100  3.94  10  0.39  59  2.34  ND  ND 
EGTA/IO0 mM NaC1  75  2.94  ND  ND  55  2.17  ND  ND 
* Percentage of ezrin released from  ~l- and a-actin-Sepharose-4B  affinity  columns in the presence of EGTA. Ezrin  was identified by western blotting as described 
in Materials and Methods. Bands were quantified by whole band analysis using a Bioimage  electrophoresis analyzer (Millipore Corp.). 
Molar ratios ezrin/actin (× 104). The amount of ezrin present in column elutions was calculated as a fraction of a known standard (unfractionated lysate; 7.7 
pmol/l(P cells); and the molar ratio determined by the moles ezrin bound/mole  actin Sepharose-4B, where the concentration  of actin conjugated to Sepharose-4B 
is 5 #M. 
§ ND = not detectable. 
creases with cell motility (see Fig. 5). We cannot detect ezrin 
p55 when lysates are prepared in the presence of EGTA (Fig. 
2,  lane 2),  nor in any of our  1 M  KC1 elutions  from a- or 
l}-actin affinity columns (Fig. 2, lanes 2-13).  Ezrin-iS-actin 
interactions  can  be  sustained  in  the  presence  of 0.2  mM 
CaCI2 when either of the two calpain I-specific inhibitors, 
E64  (L-tmns-epoxysuccinyl-leucylamido[4-guanidino]bu- 
tane) or calpain inhibitor I (N-Ac- [leucyl]2-norleucinal) are 
included in the extraction and affinity fractionation buffers 
(Barrett et al.,  1982; Tusjinaka et al.,  1988) (Fig. 2, lane 7; 
Table I). 
(Fig. 3, lane 2).  In addition to the ezrin and ~-actin present 
in the co-precipitates, there is one prominent band at 45 kD, 
and another at approximately 73 kD (Fig. 3, lane 1, asterisk), 
which is most likely p73 seen in the 1.0 M releasate from the 
~-actin column (Fig.  1, lane 4).  The 45-kD polypeptide is 
Cytochalasin  D Inhibits Association of  Ezrin with 
/3-actin Sepharose-4B 
To test whether ezrin binding to/3-actin occurs via the ends 
or along the sides of the/3-actin filament,  we next asked if 
cytochalasin  D  treatment  of phalloidin-stabilized  /3-actin 
filament  matrices  could prevent  ezrin's association.  When 
ezrin-containing E~ are percolated over j3-actin-Sepharose- 
4B columns in the presence of 2  #M cytochalasin D, ezrin 
binding to/3-actin is completely blocked (n =  4) (Fig. 2, lane 
13). The CD inhibition of ezrin binding is reversible,  since 
ezrin and bABP binding to ~3-actin Sepharose-4B is restored 
when CD is  washed from the column.  This  indicates  that 
the effect is not due to CD-induced depolymerization of the 
actin filaments.  Electron  microscopy of negatively stained 
phalloidin-stabilized  actin filaments treated with 2  #M CD 
also confirms that cytochalasin D is not depolymerizing ac- 
tin  from the affinity columns (Shuster,  C.  B.,  unpublished 
observations),  but does not rule out the possiblity that an- 
other  /3-actin-specific  binding  protein  is  responsible  for 
mediating  the  CD-sensitive/3-actin  capping/ezrin  associa- 
tion (see below)  (Figs.  8  and 9). 
Association of  Ezrin and [3-actin In Vivo: 
Co-precipitation  Using Covalent Cross-linkers 
To reveal whether an ezrin-/3-actin complex could be iso- 
lated  from living  cells,  co-immune precipitation  was  em- 
ployed. To stabilize ezrin-/3-actin interactions prior to cell 
lysis, biosynthetically labeled cells were treated with DSP as 
described (see Materials and Methods). Fluorographic anal- 
ysis of immune precipitates electrophoresed on 7.5 % poly- 
acrylamide  gels  reveals  that/3-actin  and  ezrin  can be  co- 
precipitated  using  anti-actin  IgG  (Fig.  3,  lane  1).  Ezrin 
cannot, on the other hand, be co-precipitated from the DSP 
cross-linked,  ct-actin-containing  stress  fiber  fraction  (Es) 
Figure 3.  Co-precipitation of ezrin and B-actin  from DSP cross- 
linked cytoplasm. Retinal pericytes were labeled  with 85 #Ci/ml 
[35S]methionine/[35S]cysteine for  10 h.  Cells  were washed  three 
times with PBS prior to treatment  of 0.25 mM Dithiobis[succini- 
midylpropionate] (DSP) in PBS/0.005 % digitonin for 10 rain. Lysis 
and immunoprecipitation were performed on Triton-soluble  (lanes 
1 and 3) and SDS-soluble (lanes 2 and 4) fractions as described 
(Yost and Herman, 1990). Precipitates  were washed, solubilized in 
SDS-PAGE sample  buffer. Samples were resolved  on 7.5 % SDS- 
PAGE, and processed for fluorography. (Top  arrow) Ezrin; (Bottom 
arrow) actin;  (Asterisk) lO73 (lane  1).  (Lanes 1 and 2) Anti-actin 
immunoprecipitates  from Triton-soluble  (lane 1 ) and SDS-soluble 
(lane  2) lysates.  (Lanes 3 and 4) Anti-ezrin immunoprecipitates 
from Triton-soluble (lane  3) and SDS-soluble (lane  4) lysates. 
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blotting), and the 73 kD species is novel and under study. 
Ezrin and f3-Actin are Co-localized within Leading 
LameUae and Rearward Protrusions 
Because ezrin associates specifically with/~-, but not tx-actin 
filaments in vitro, we examined whether the proteins are co- 
localized within cells.  We turned to our "wound healing" 
model, where we have already demonstrated that/~-actin and 
its encoding mRNA are rapidly recruited and retained within 
the advancing protrusions of crawling cells, which migrate 
in response to monolayer injury in vitro (Hoock et al., 1991). 
Using  affinity-selected anti-fl-actin  IgG  and  monoclonal 
anti-ezrin IgG,  we can  simultaneously localize ezrin and 
/3-actin  within the distal reaches of advancing protrusions 
and in membrane veils undergoing rapid ruffling (Fig.  4). 
Broad fan lamellae that slowly extend forward as  well as 
rearward regions that are released from contact inhibition 
are also/~-actin and ezrin-rich (data not shown). Bright foci 
of ~-actin  and  ezrin  (1.32  +  0.4  #m  2)  can  also  be  seen 
within the ventral aspects of forward protrusions behind the 
leading edge, and in apical projections that move centripe- 
tally toward the nucleus (Fig. 4, A and B). These co-local- 
ization patterns are independent of the nonmuscle cell type 
studied, i.e., in each case, ezrin and ~-actin are exclusively 
seen  within  the  membrane-cytoskeletal interface and  are 
particularly prevalent within domains that engage in cyto- 
plasmic remodelling, either during cell locomotion or pro- 
trusion formation. 
Ezrin Proteolysis Is Elevated in Motile Cells 
Based  on results  of isoactin  affinity fractionation experi- 
ments  where  Ca2÷-activated  calpain  I  modulates  ezrin-/3- 
actin interactions, we wished to determine whether such a 
mechanism might be in place in  crawling cells.  To these 
ends, extracts were derived from populations of stationary 
endothelial cells and those undergoing a uniform, migratory 
response to injury. Confluent monolayers of endothelial cells 
were injured with a rake that creates concentrically uniform, 
denuded zones that  are 400-600  #m  in  width  (Herman, 
1993c). Following injury and during the recovery (motile) 
phase, cultures were lysed and probed for the presence of in- 
tact and ezrin p55 with polyclonal anti-ezrin IgG. Western 
blotting reveals the accumulation of ezrin p55 by 30 min af- 
ter injury, which persists through the motile, wound-healing 
phase (Fig. 5). During post-injury motility, ezrin p55 levels 
are 14-18-fold greater than at the time of injury. 
Cytosolic-free Calcium Is Transiently Elevated within 
Ezrin and #-Actin-enriched Cytoplasmic Domains 
Results from the isoactin affinity fractionation, co-immune 
precipitation and antibody localization studies indicate that 
ezrin  and  /~-actin  interact in  a  calcium-sensitive fashion. 
Could  local  elevations  in  free  calcium  be  found  in  ez- 
rin-actin-rich cytoplasmic domains during the migratory re- 
sponse to injury in vitro? Using fluo-3 and confocal micros- 
copy qualitative assessments of free calcium transients were 
made in endothelial cells recovering from injury in vitro. 
Image  analysis  of fluo-3  fluorescence across  the  injured 
monolayer reveals that cells crawling at the wound edge pos-' 
sess a threefold greater level of free calcium than those cells 
within the resting monolayer, which are 7.5-8 cell diameters 
from the injury site (Fig.  6).  Within forward protrusions, 
bursts of fluo-3 fluorescence emerge and then disappear as 
moving cytoplasm advances along the wound edge. Bright 
perinuclear and organellar fluorescence can also be seen. 
Figure 4. ~actin and ezrin are co-localized in leading lamellae. Bovine endothelial ceils were plated at confluence onto glass coverslips. 
Monolayers were injured as described and allowed to recover for 60 min at 37"C prior to fixation and permeabilization (Hoock et al., 
1991). Cells were stained simultaneously with affinity-selected anti-/~-actin IgG (detected with rhodamine-Iabeled goat anti-rabbit  IgG) 
(.4) and monoclonal anti-ezrin IgG (detected with fluorescein-labeled goat anti-mouse IgG) (B). Bar, 10 t~m. 
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elevated in motile  cells.  Bo- 
vine endothelial  cells,  which 
are plated  at confluence,  are 
injured  as  described  (Her- 
man,  1993c). Cells  are  al- 
lowed to  recover  from 0-90 
min after injury. Lysates are 
then  prepared  from crawling 
or  control  cells.  Lanes  1-4, 
Western blot,  anti-ezrin IgG. 
Arrow  indicates  the  emer- 
gence  of ezrin  p55, the  cal- 
pain  I-generated  proteolytic 
breakdown product.  (Lane 1 ) 
Control, no motility (0 time). 
(Lane 2) 30 min after injury. 
(Lane  3)  60  min  after  in- 
jury.  (Lane  4)  90  min  after 
injury. 
Within live cell cultures, 45%  +  2.18 of fluo-3 fluorescence 
is observed as discrete focal domains occupying 2.7  +  2 
/~m  2. In other cells 12%  5:2.33  of the fluo-3 fluorescence 
is diffuse, extending back from the wound edge, enveloping 
the entire cortex and occupying roughly 67  +  28.8 t~m  2. In 
9 % of cells bordering the wound edge, the entire cytoplasm 
is filled with a  low level of fluo-3 fluorescence. 
Following confocal imaging of fluo-3 fluorescence in live 
cell cultures, we mapped regions of overlap between free cal- 
cium, ezrin and fl-actin by fixing the identical cultures and 
preparing them for double antibody staining.  Co-localiza- 
tion reveals that fluo-3 fluorescence maps to within 70%  + 
2.5 of the ezrin- and B-actin-rich domains (Fig. 6).  Quan- 
titative analysis reveals that ezrin is localized within 2.6  + 
1.8 #m of the leading edge (n =  38), and is found exclusively 
in  the  cortex  (Fig.  6).  /g-actin  is present within  the  ezrin 
"shell," extending only 1.57  +  0.77 #m from the leading edge 
(n  =  38) (Fig.  6).  Fluo-3 fluorescence envelops the entire 
ezrin-/3-actin-rich  zone,  leaving  a  statistically  significant 
area of overlap of ~1.35 t~m. A t-test reveals that non-overlap 
between ezrin and free calcium is not statistically significant 
(P  =  0.427). 
Pericyte Ezrin Does Not Directly Bind #-Actin 
Filaments In Vitro 
Co-sedimentation  and  Co-immunoprecipitation.  To  ad- 
dress  whether  ezrin  binds  B-actin  filaments  directly  or 
through other components, we mixed homogeneous prepara- 
tions of ezrin with c~- or/3-actin filaments in vitro. 0.5 I~M 
hydroxylapatite- and DE-52-purified pericyte ezrin (Fig. 7) 
Figure 6.  Simultaneous map- 
ping  of free  calcium  in  ez- 
rin-#-actin-rich  cytoplasmic 
domains.  Bovine  endothelial 
cells were plated at confluence 
and injured in the presence of 
5 ~M Fluo-3. Cells  were al- 
lowed to recover for 25 min at 
37°C, prior to mounting on a 
warmed chamber slide. Fluo-3 
fluorescence  was  monitored 
by confocal  microscopy,  and 
qualitative differences in free 
calcium levels are shown in A 
as  a  histogram  of  fluo-3 
fluorescence observed in cells 
bordering  both  sides  of the 
wound edge,  with each peak 
representing the fluorescence 
of  a single cell along its x-axis. 
Cortical-free  Ca  z+  in  cells 
bordering the wound edge are 
shown in B. Following image 
capture,  cells were fixed and 
processed  for ezrin  (C)  and 
/~-actin (D) localization.  Bar, 
10 ~m. 
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cyte ezrin.  (Lanes 1-3) Coo- 
massie brilliant  blue  R-250. 
(Lane 4) Western blot, anti- 
ezrin IgG. Em extracted from 
subconfluent  cultures  of bo- 
vine retinal pericytes (lane 1 ) 
was  chromatographed  over 
hydroxylapatite  as  described 
in  Materials  and  Methods. 
Ezrin-enriched fractions were 
pooled  (lane  2)  and  re- 
chromatographed over DEAE 
cellulose.  The  0.1  M  NaC1 
fraction  eluted  from  the 
column  contains  purified  ez- 
rin (lane 3) as confirmed by 
Western blotting using rabbit 
anti-ezrin IgG (lane 4). 
were mixed together with either 0.5 #M c~- or/3-actin under 
physiological ionic conditions and over a pH range (7.0-8.5) 
prior to sedimentation of actin filaments at 110,000 g. Taking 
into account our earlier isoactin affinity fractionation data 
indicating that ezrin putatively binds to the barbed end of the 
~-actin filament (Fig. 2, lane 13),  affinity-purified pericyte 
ezrin (8-16 nM) was combined at ratios that were 5-10-fold 
greater than the estimated number of free isoactin filament 
ends. Examination of soluble and pellet fractions reveals that 
ezrin cannot be co-sedimented with either or- or/~-actin fila- 
ments under any condition (n =  12) (Fig. 8). Further, as we 
have demonstrated that ezrin present within lamellar lysates 
associates with/~-actin-Sepharose 4B, it can also be shown 
that ezrin sediments with fl-actin when this isoactin is added 
to the lamellar lysate (Fig.  8).  Increasing actin concentra- 
tions or altering the incubation temperature/time yielded 
identical results (data not shown). As an alternative, perhaps 
more sensitive means of assessing these protein-protein in- 
teractions,  we again employed our actin antibodies  to co- 
precipitate ezrin/isoactin complexes from these purified pro- 
tein mixtures. Western blotting of actin immunoprecipitates 
indicates that ezrin cannot be detected in the immunoprecipi- 
tates of either or- or/~-actin filaments pre-incubated in the 
presence of ezrin (data not shown). 
lsoactin AJfinity Fractionation.  As a final assessment of 
whether ezrin binding to/~ actin is direct, we applied purified 
ezrin to the  isoactin Sepharose-4B columns under experi- 
mental conditions identical to those we had initially estab- 
lished as being supportive for the/3-actin-ezrin interactions 
described in Fig. 2. Western blotting of the unbound fraction 
as well as the material released with  1.0 M  NaCI indicates 
that ezrin does not directly bind to either a-or ~-actin affinity 
columns,  while  control  experiments  using  Em  containing 
ezrin reaffirms our earlier results,  which suggest that ezrin 
binding to B-, but not ot-actin is specific, indirect, and most 
likely  to  be  mediated  through  other  accessory protein(s) 
(Fig.  9). 
Discussion 
We have been able to conclusively demonstrate that ezrin, 
one member of the recently discovered ERM family of puta- 
tive tumor suppressor proteins (Tsukita et al.,  1993), inter- 
acts specifically with ~-, but not ot-actin filaments. Further, 
this association is sensitive to calcium, through the action of 
calpain I. The in vitro association between/$-actin and ezrin 
is not only consistent with their co-localization within distal 
reaches of forward protrusions, but is also supported by the 
transient increase of cytosolic free calcium within the ez- 
rin-/3-actin-enriched cell cortex. In addition,  we find that 
when cells undergo a migratory response to injury and posi- 
tion both ezrin and/3-actin in leading lameUae, ezrin proteol- 
ysis  is  elevated.  Co-immune  precipitation  of ezrin  from 
E~-derived lysates using actin antibodies confirms both the 
morphological and biochemical observations and  suggests 
that the two proteins are, indeed,  interactive in vivo. How- 
ever, co-sedimentation, co-precipitation, and isoactin affin- 
ity fractionation experiments reveal that a direct interaction 
between ezrin and ~-actin is unlikely, since homogenous, na- 
tive preparations of ezrin fail to bind either isoactin under 
any  experimental  condition  tested.  The  results  of  these 
studies suggest that ezrin most likely interacts with a ~-actin- 
Figure 8.  Co-sedimentation analysis 
of  ezrin-actin  interactions.  Ezrin 
was incubated alone or in the pres- 
ence of filamentous (0.5 #M, a or/~) 
actin prior to pelleting by centrifuga- 
tion (middle, purified Ezrin). Alter- 
natively,  the  identical  experiment 
was  performed  using  lamellar  ex- 
tracts  (right,  Era). Supernatant  (S) 
and  pellet  (P)  fractions  were  ana- 
lyzed  by  Western  blotting  with 
anti-ezrin  IgG.  Actin  polymerized 
and pelleted in the absence of ezrin 
is  shown  (left,  Coomassie  brilliant 
blue  R-250  staining).  Molecular 
weight markers  in kD are shown). 
The  addition  of  ezrin  does  not 
influence  the  amount  of  actin 
sedimented. 
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purified pericyte ezrin. Pericyte ez- 
rin (le3~  panel)  was incubated with 
ct-or  #-actin  Sepharose-4B under 
conditions  described for  affinity 
fractionation of F_~-derived lysates 
(Figs.  1,  2  and  right panel).  For 
controls,  Em  was  percolated over 
ct- or ~-actin Sepharose-4B follow- 
ing its pre-absorbtion over ct-actin 
Sepharose-4B  (right  panel).  Col- 
umns were washed and eluted as de- 
scribed,  and  the  protein  that  re- 
mained unbound, or that which was 
released  with  1.0  M  NaCI was 
probed  by  Western blotting with 
anti-ezrin  IgG  (lanes 1-4,  both 
panels).  (Lane/) Unbound fraction 
from c~-actin  Sepharose-4B. (Lane 2) 
1.0  NaCI elution  from  c~-actin 
Sepharose-4B.  (Lane  3)  Unbound 
fraction from/3-actin Sepharose-4B. 
(Lane  4)  1.0  NaCI elution  from 
/~-actin Sepharose-4B. 
specific binding protein, and that proteolytic modification of 
ezrin dissociates it from the ~-actin filament complex. 
Ezrin Association  with F-Actin Isoform Specificity 
Binding of ezrin of F-actin is currently controversial. Origi- 
nally, ezrin was not considered to be an actin-binding pro- 
tein,  as  it  did  not  associate  with  muscle  actin  in  vitro 
(Bretscher,  1983, 1991). More recently, it has been reported 
that ezrin does contain an actin-binding domain at its COOH 
terminus. Independent expression of this decapeptide dem- 
onstrates that it possesses a strong affinity for both skeletal 
muscle and cytoplasmic actin (Turenen et al.,  1994).  Our 
data suggest that the actin-binding activity of the expressed 
COOH-terminal domain may not reflect the behavior of the 
intact, native ezrin molecule, since we could not detect any 
binding of skeletal muscle actin, and no direct association 
with/~-actin. 
In our hands, only ezrin contained with cell lysates (de- 
rived from moving cytoplasm) associates with ~-, but not 
~-actin filaments in vitro (Fig. 2, 8, and 9). Purified, intact 
ezrin does not bind to either isoactin affinity columns or na- 
tive filaments when the identical experiments are performed 
with  purified  molecules  (Fig.  9).  Co-sedimentation and 
-immunoprecipitation experiments designed to detect direct 
binding between affinity-purified  ezrin and/~-actin filaments 
fail to reconstitute this interaction (Fig. 8). This suggests that 
one or more polypeptides present in the lamellar lysates, 
which do not bind ~-actin, potentiates ezrin binding to the 
~-actin filament. There are five possible polypeptides eluting 
from ~-actin affinity columns along with ezrin (Fig. 1 ) that 
might be responsible for such an interaction. Co-precipita- 
tions of ezrin and 5-actin (from labeled cell lysates) contain 
a polypeptide of '~73 kD (Fig.  3),  which does not bind to 
~-actin and is also present in the ~-actin column releasates 
(Fig. 1). It is possible that ezrin binds p73, which in turn caps 
the barbed end of the/~-actin filament. That cytochalasin D 
blocks ezrin binding to/3-actin when p73 is present suggests 
that this is, indeed, the case. 
Morphological studies examining actin interactions with 
the plasma membrane have reported that actin is joined to 
the plasma membrane at its ends and along its sides (Luna 
and Hitt, 1993).  End-on associations of actin filaments with 
the plasma membrane have been described in several model 
systems, including the intestinal epithelial cell brush border, 
where  bundled  arrays  of actin filaments terminate at  the 
plasma  membrane  via  their  barbed  ends  (reviewed  by 
Bretscher,  1991). The pointed ends of actin filaments have 
also been shown to interact with the plasma membrane in the 
advancing front of nerve growth cones (Lewis and Bridg- 
man, 1992).  Lateral associations of actin filaments with the 
plasma  membrane  have  also  been  documented.  In  Dic- 
tyostelium, actin filament-membrane interactions are medi- 
ated  through  an  integral  membrane  protein,  ponticulin 
(Wuesteuhube and Luna, 1987).  Ponticulin organizes actin 
by binding the  sides of filaments, but this binding is  not 
isoactin-specific. Our own immunoelectron microscopic ex- 
amination of/~-actin filament organization in leading lamel- 
lae  and  other  forward  protrusions  indicates  that  short 
stretches of 13-actin filaments (7-10 molecules in length) ter- 
minate at the plasma membrane.  From these anti-~-actin 
IgG-decorated nuclei, undecorated ~,-actin-containing fila- 
ments could extend (Shujath, J., and I. M. Herman, unpub- 
lished observations). Our biochemical data, which indicates 
that cytochalasin D blocks the interaction of ezrin/p73  with 
~-actin in vitro (Fig. 2), suggests that the ezrin/p73  complex 
associates at or in close approximation to the fast growing 
end of the/~-actin nucleus, at the plasma membrane (Figs. 
2 and 3). Indeed, studies using fluorescent derivatives of ac- 
tin in permeabilized cell models suggest that a  regulated, 
barbed-end capping activity exists at the tips of lamellipodia 
(Symons  and  Mitchison,  1991). Collectively,  these  data 
point to a possible role for ezrin in tethering a/3-actin fila- 
ment capping complex at the plasma membrane. However, 
The Journal of Cell Biology, Volume 128,  1995  846 more work is required  before the details of these putative 
events are understood. 
Ca  2+-activated  Proteolysis Regulates 
Ezrin-C3-Actin Interactions 
Our results performing isoactin affinity  fractionation in the 
presence of calcium and/or calpain-specific inhibitors reveal 
that ezrin undergoes a calpain I-mediated cleavage, and this 
abolishes its ability to associate/~-actin in vitro (Fig. 2). And 
in vivo, there is an accumulation of the ezrin p55 proteolytic 
breakdown product  as cells polarize and crawl in response 
to monolayer injury. This is not the first report indicating that 
modulation  of protein-protein  interactions  can  occur  by 
calcium-activated proteolysis. During platelet activation, lo- 
cal elevations of intracellular  calcium induce an autolytic 
cleavage of calpain I, activating  the protease (Saido,  1992). 
In its  activated  state,  calpain I  is  localized at the plasma 
membrane, where it acts on filamin and fodrin (Fox et al., 
1985; Saido et al., 1993). Also, activation of erythrocyte cal- 
pain I (with ionophores) results  in protein 4.1 and spectrin 
degradation  (Hayashi  et al.,  1991).  More pertinent to our 
findings are indications that calpain I mediates the limited 
proteolysis of parietal cell ezrin both in vitro and in vivo. In 
vivo, calpain I-mediated degradation of parietal cell ezrin 
results  in  the  inhibition  of proton  secretion  (Yao  et  al., 
1993).  Based on these findings, we postulate that/3-actin- 
ezrin interactions may be regulated  via a calpain-mediated 
cleavage. The calpain-mediator turnover of ezrin, as well as 
other cytoskeletal components, may facilitate the remodel- 
ling of the actin cytoskeleton, and allow for new monomer 
addition  at the plasma  membrane within forward protru- 
sions. Our observations that cytosolic-free calcium is tran- 
siently elevated in forward protrusions and that ezrin pro- 
teolysis is also elevated in motile cells lends credence to this 
notion (c.f.  Figs.  5 and 6). 
It should be pointed out that elevations in free calcium 
have been carefully monitored in single crawling cells using 
ratio imaging analysis (Hahn et al.,  1992;  Brundage  et al., 
1991). Results reveal that the highest free calcium concentra- 
tion is present in the trailing,  contracting portion of the cell 
(Hahn et al.,  1992;  Brundage et al.,  1991).  Based on this 
work, it has been proposed that elevated free calcium leads 
to  myosin  R-mediated  contraction  of  the  posterior 
cytoplasm,  therein  providing a protrusive force propelling 
cytoplasm and actin monomers forward for polymerization at 
the leading lamellae (Gough  and  Taylor,  1993).  However, 
computer-assisted analysis of endothelial motility following 
injury  reveals  a  deliberate,  sheet-like  migration  of  the 
monolayer where pseudopodial and lamellar extension occur 
in the absence of any significant rearward contraction (Askey 
and Herman,  1988;  Herman,  1993b). All of these observa- 
tions are consistent with our present work, which reveals that 
calcium is transiently  elevated within leading lameUae in the 
majority of cells surveyed  along the wound edge (Fig.  6). 
This temporal and spatial rise and fall of free calcium in dis- 
crete cytoplasmic domains may dictate where calpain I could 
cleave ezrin and release/3-actin for barbed end assembly. It 
will be important to reveal  whether p73  is not capable of 
binding ezrin after Ca2÷/calpain-mediated  cleavage or it p73 
dissociates from the/3-actin filament with ezrin p55. Current 
studies are focused on these open questions. 
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